NY-ESO-1-specific CD4-positive T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-015574
A preparation of autologous CD4+ T-lymphocytes sensitized to cancer-testis antigen NY-ESO-1, with potential immunostimulating and antineoplastic activities. CD4-positive T-lymphocytes are exposed to a NY-ESO-1 peptide ex vivo, expanded, and introduced into the patient. The NY-ESO-1-specific CD4-positive T-lymphocytes may stimulate the host immune system to produce a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the NY-ESO-1 antigen, which results in tumor cell lysis. NY-ESO-1, an antigen found in normal testis, may be upregulated in various cancers.
| Identifier | MLC-T-ONC-015574 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | CD4+ NY-ESO-1-specific T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015574",
"term": "NY-ESO-1-specific CD4-positive T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous CD4+ T-lymphocytes sensitized to cancer-testis antigen NY-ESO-1, with potential immunostimulating and antineoplastic activities. CD4-positive T-lymphocytes are exposed to a NY-ESO-1 peptide ex vivo, expanded, and introduced into the patient. The NY-ESO-1-specific CD4-positive T-lymphocytes may stimulate the host immune system to produce a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the NY-ESO-1 antigen, which results in tumor cell lysis. NY-ESO-1, an antigen found in normal testis, may be upregulated in various cancers.",
"synonyms": [
"CD4+ NY-ESO-1-specific T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ny-eso-1-specific-cd4-positive-t-lymphocytes/"
}
Record 12,050 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.